MTAP and T-cell acute lymphoblastic leukemia: Although there have been no reports of single pralatrexate use for MTAP-null tumors, it has been shown to be effective on MTAP-deficient T-cell acute lymphoblastic leukemia (T-cell ALL) when used in combination with 6-thioguanine [142].